Accendra Health (ACH) director receives 31,191 restricted shares in equity grant

Rhea-AI Filing Summary

Gardner-Smith Kenneth reported acquisition or exercise transactions in this Form 4 filing.

Accendra Health Inc. director Kenneth Gardner-Smith received a grant of 31,191 shares of Common Stock as restricted stock on May 14, 2026. These shares were awarded at no cash cost and increase his direct holdings to 86,113 shares.

The restricted stock grant vests on the earlier of one year from the grant date or the next annual meeting that is at least 50 weeks after the grant date, meaning the award is tied to continued board service over roughly a one-year period.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gardner-Smith Kenneth

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	31,191	$0.00	--

Holdings After Transaction: Common Stock — 86,113 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted shares granted: 31,191 shares Transaction price per share: $0.0000 per share Shares held after grant: 86,113 shares

3 metrics

Restricted shares granted 31,191 shares Common Stock grant on May 14, 2026

Transaction price per share $0.0000 per share Equity compensation, not a cash purchase

Shares held after grant 86,113 shares Director’s direct Common Stock holdings following transaction

Key Terms

Restricted stock grant, Common Stock, annual meeting

3 terms

Restricted stock grant financial

"Restricted stock grant which vests the earlier of (i) one year from the grant date..."

A restricted stock grant is an award of company shares given to an employee or executive that cannot be sold or transferred until certain conditions are met, such as staying with the company for a set time or hitting performance goals. For investors, it signals how the company ties pay to future performance and can affect the number of shares outstanding and management’s incentives—think of it as a wrapped gift you only keep once you meet the requirements.

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

annual meeting financial

"the date of the next annual meeting that is at least 50 weeks following the grant date"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gardner-Smith Kenneth

(Last) (First) (Middle)

ACCENDRA HEALTH, INC.

4435 WATERFRONT DRIVE

(Street)

GLEN ALLEN VIRGINIA 23060

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACCENDRA HEALTH INC/VA/ [ ACH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	05/14/2026		A		31,191	A	$0	86,113	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date.

	Kenneth Gardner-Smith by Rosemarie France, POA	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Accendra Health (ACH) report for Kenneth Gardner-Smith?

Accendra Health reported that director Kenneth Gardner-Smith received a grant of 31,191 shares of Common Stock as restricted stock. The award was recorded at no cash cost per share and represents equity-based compensation tied to his role on the board.

How many Accendra Health (ACH) shares does Kenneth Gardner-Smith hold after this grant?

After the restricted stock grant, Kenneth Gardner-Smith directly holds 86,113 shares of Accendra Health Common Stock. This total includes the newly granted 31,191 restricted shares, which are subject to vesting conditions linked to time and the company’s next qualifying annual meeting.

What are the vesting terms of the Accendra Health (ACH) restricted stock grant?

The restricted stock grant vests on the earlier of one year from the grant date or the date of the next annual meeting that is at least 50 weeks after the grant date. These conditions encourage continued board service over approximately a one-year period before full ownership.

Was cash paid for the Accendra Health (ACH) shares granted to Kenneth Gardner-Smith?

No cash was paid for the shares in this grant; the transaction price per share was reported as 0.0000. This indicates the 31,191 shares were issued as equity compensation, not purchased in an open-market transaction or for cash consideration by the director.

Is the Accendra Health (ACH) Form 4 transaction an open-market buy or a compensation grant?

The Form 4 shows a compensation-related grant, not an open-market purchase. The transaction is coded “A” for a grant, award, or other acquisition, with 31,191 restricted shares awarded at no cash cost, subject to specified vesting conditions tied to time and the annual meeting.